EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lung cancer: chemo-radiation combo tested after first treatment fails
Disease control Not yet recruitingThis study tests a combination of a chemotherapy drug (nab-paclitaxel) and local radiation therapy for people with advanced small-cell lung cancer whose disease got worse after initial treatment. The goal is to see if this approach can control the cancer longer and with fewer sid…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug combo aims to shrink tough lung cancers
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in people with extensive-stage small cell lung cancer whose cancer has already been treated. The goal is to see if the combination can shrink tumors. About 33 adults aged 18 to 75 with good perfor…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 19, 2026 12:01 UTC